United States - English - NLM (National Library of Medicine)

onyx premiere llc - alcohol (unii: 3k9958v90m) (alcohol - unii:3k9958v90m) - hand sanitizer to help reduce bacteria on the skin.

Australia - English - Department of Health (Therapeutic Goods Administration)

medtronic australasia pty ltd - 56284 - drug-eluting coronary artery stent, non-biodegradable-polymer-coated - the onyx frontier stent is manufactured from cobalt platinum iridium alloy. the delivery system consists of a balloon-expandable intracoronary stent premounted on the delivery system with a catheter; for stent sizes 2.0?4.0mm and 4.5 and 5.0mm, the stent is delivered by the onyx frontier and resolute onyx rapid exchange (rx) delivery system, respectively. the onyx frontier stent with the active drug zotarolimus is intended to reduce the incidence of restenosis in coronary interventions. the stent is intended to improve coronary luminal diameters of either single or multiple vessels, as an adjunct to coronary interventions and to reduce restenosis. the stent is intended as a permanently implanted device. the onyx frontier stent system is intended for use in patients eligible for percutaneous transluminal coronary angioplasty (ptca) with a reference vessel diameter of 2.0 mm to 5.0 mm. the stent is indicated for the treatment of the following patient and lesion subsets: one month of dual antiplatelet therapy (dapt) in high bleeding risk (hbr) patients, including patients who are unable to tolerate long-term dapt diabetes mellitus multivessel disease acute coronary syndrome (acs) acute myocardial infarction (ami) unstable angina (ua) bifurcation lesions in-stent restenosis (isr) chronic total occlusions (cto) total occlusions (to) left main (lm) small vessel (sv)

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

onyx vision sdn. bhd. - eurycoma longifolia -

United States - English - NLM (National Library of Medicine)

uriel pharmacy inc. - bifenthrin (unii: 6b66jed0kn) (bifenthrin - unii:6b66jed0kn) - directions: for topical use only. use: temporary relief of headache.

United States - English - NLM (National Library of Medicine)

uriel pharmacy inc. - bifenthrin (unii: 6b66jed0kn) (bifenthrin - unii:6b66jed0kn) - directions: for oral use only. use: temporary relief of headache.

Australia - English - Department of Health (Therapeutic Goods Administration)

medtronic australasia pty ltd - 35449 - prosthesis, internal, embolization, intravascular - liquid onyx is delivered through a dmso primed microcatheter placed within a feeding pedicle of an avm or an aneurysm. the dmso priming volume separates onyx from blood, saline or contrast media within the cathteter lumen that may cause early precipitation and catheter occlusion. onyx material is injected at a slow rate. solidification of the material begins immediately upon injection, beginning as a "skin" on the outside of the mass./ total solidification occurs within minutes. embolization of intracranial aneurysms and lesions in the peripheral and neurovasculature including arteriovenous malformations and hypervascular tumours.

Singapore - English - HSA (Health Sciences Authority)

medtronic international, ltd. - cardiovascular - the resolute onyx™ stent system is intended for use in patients eligible for percutaneous transluminal coronary angioplasty (ptca) with a reference vessel diameter of 2.0 mm to 5.0 mm. the resolute onyx™ stent is indicated for the treatment of the following patient and lesion subsets: - diabetes mellitus - multivessel disease - acute coronary syndrome (acs) - acute myocardial infarction (ami) - unstable angina (ua) - bifurcation lesions - in-stent restenosis (isr) - chronic total occlusions (cto) - total occlusions (to) - left main (lm) - small vessel (sv) - one month of dual antiplatelet therapy (dapt) in high bleeding risk (hbr) patients, including patients who are unable to tolerate long-term dapt. the resolute onyx™ stent is intended to improve coronary luminal diameters of either single or multiple vessels as an adjunct to coronary interventions and to reduce restenosis. the stent is intended as a permanently implanted device.

Australia - English - Department of Health (Therapeutic Goods Administration)

medtronic australasia pty ltd - 56284 - drug-eluting coronary artery stent, non-biodegradable-polymer-coated - the resolute onyx stent is manufactured from a composite material of cobalt alloy and platinum iridium alloy.the delivery system consists of a balloon-expandable intracoronary stent premounted on the resolute onyx rx delivery system with a catheter.the resolute onyx stent with the active drug zotarolimus is intended to reduce the incidence of restenosis in coronary interventions. the resolute onyx stent system is intended for use in patients eligible for percutaneous transluminal coronary angioplasty (ptca) with a reference vessel diameter of 2.0 mm to 5.0 mm. the resolute onyx stent is indicated for the treatment of the following patient and lesion subsets: ? one month of dual antiplatelet therapy (dapt) in high bleeding risk (hbr) patients, including patients who are unable to tolerate long term dapt ? diabetes mellitus ? multivessel disease ? acute coronary syndrome (acs) ? acute myocardial infarction (ami) ? unstable angina (ua) ? bifurcation lesions ? in-stent restenosis (isr) ? chronic total occlusions

Singapore - English - HSA (Health Sciences Authority)

covidien private limited - neurology - embolization of lesions in the peripheral and neurovasculature, including arteriovenous malformations and hypervascular tumors. the onyx-34l models are indicated for the embolization of lesions in the peripheral vasculature, including endoleaks, arteriovenous malformations, portal veins, bleedings and tumors.

Singapore - English - HSA (Health Sciences Authority)

sg medical pte ltd - general hospital - the intended use to the nonin® onyx vantage 9590 finger pulse oximeter is a small,lightweight,portable device indicated for use in measuring and displaying functional oxygen saturation of arterial haemoglobin (%spo2)and pulse rate of patients who are well or poorly perfused.it is intended for spot-checking of adult and pediatric patients on digits(fingers,thumb,toes) that are between 0.3-1.0 inch(0.8-2.5cm) thick